Blaise Coleman, Endo International CEO

En­do files for Chap­ter 11 as it looks to fin­ish off its opi­oid lit­i­ga­tion

Irish drug­mak­er En­do In­ter­na­tion­al is en­ter­ing in­to bank­rupt­cy as it faces the weight of se­ri­ous lit­i­ga­tion re­lat­ed to its in­volve­ment in the opi­oid epi­dem­ic in the US.

The com­pa­ny has filed Chap­ter 11 pro­ceed­ings in the US Bank­rupt­cy Court for the South­ern Dis­trict of New York, with the com­pa­ny ex­pect­ed to file recog­ni­tion pro­ceed­ings in Cana­da, the UK and Aus­tralia. The com­pa­ny’s bank­rupt­cy fil­ing showed the com­pa­ny had as­sets and li­a­bil­i­ties in the range of $1 bil­lion to $10 bil­lion.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.


Alexandria Real Estate Equities

Cambridge, MA, USA